Thanks to its skills and to the collaboration with a network of qualified professionals who share a common passion for excellence, Maxer can effectively coordinate its consulting activities for the biomedical industry, offering integrated services for the clinical research and the medical affairs department. Furthermore, it offers an innovative approach to digital marketing for the pharmaceutical world.
These activities integrate with training programmes dedicated to CTIS Clinical Trial Disclosure, Data Transparency, Lay Summaries, medical writing, text design, and digital marketing. Each project is based on proven methodologies and is inspired to the principles of respect, entrepreneurship, innovation and value creation in which all Maxer professionals can recognize themselves.
Some of our articles
CTD/DT 2026 Programme under CT.gov for Chiesi
0 CommentsExternal Guidance on the Implementation of the EMA Policy 0070: V. 1.5
0 CommentsMaxer completes the analysis of specialists’ digital behaviours
0 CommentsWhat we talk about in our blogs
Clinical Trial Transparency: insights on the regulatory evolution and debate that ensues from it, Read more →.
Market access: Paths for the diagnosis and the treatment of chronic obstructive pulmonary disease and asthma, Read more →.
The shattered myths of the web: a series of articles on the most topical issues of the web and social media, Read more →.





